Auxly Corporate Overview - 2018 Financial and Operational Highlights

Page created by Sean Freeman
 
CONTINUE READING
Auxly Corporate
Overview
2018 Financial and Operational Highlights

Auxly Cannabis Group Inc
www.auxly.com
Legal Disclaimer                                                                                        Forward-looking Information                                                                         differ materially from those expressed or implied by the forward-looking information, general
The information provided herein is not intended to provide financial, tax, legal or accounting          This corporate document contains “forward-looking statements” and “forward-looking                  business, economic and competitive uncertainties, regulatory risks including risks related to
advice. The contents hereof do not constitute an offer to sell or a solicitation of an offer to buy     information” (collectively, “forward-looking information”) within the meaning of applicable         the cannabis market in the United States and Canada, market risks, dict all of such factors
securities of the Auxly Cannabis Group Inc (the “Company”) or represent an intention to in-             securities legislation.” Thereafter, all references should be to “forward-looking informa-          and to assess in advance the impact of each such factor on the Company’s business or the
duce any person to make an investment in the Company or to assist any person in the making              tion”). This corporate document may use words such as “may”, “would”, “could”, “will”,              extent to which any factor, or combination of factors, may cause actual results to differ ma-
of an investment decision. Information provided on this website is for information purposes             “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”,   terially from those contained in any forward-looking statements. Forward-looking informa-
only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities,   “outlook”, and other similar expressions to identify forward-looking statements. In addi-           tion contained in this Presentation is based on the Company’s current estimates, expecta-
nor shall there be any sale of securities in any state in the United States of America in which         tion, the Company’s assessment of, and targets for, future cultivation, production timelines,       tions and projections, which the Company believes are reasonable as of the current date.
such offer, solicitation or sale would be unlawful. This Presentation includes market share,            average margin on streaming transactions, investment returns on streaming transactions,             The Company can give no assurance that these estimates, expectations and projections will
industry and other statistical information that the Company has obtained from independent               average selling prices, cost of goods sold, o  ­ perating expenses and adjusted EBITDA are          prove to have been correct. Historical statements should not be taken as a representation
industry publications, government publications, market research reports and other published             considered forward-looking statements. Actual results, performance or achievement could             that such trends will be replicated in the future. No statement in this Presentation is intend-
independent sources. Such publications and reports generally state that the information con-            differ materially from that expressed in, or implied by, any forward-looking statements in          ed to be nor may be construed as a profit forecast.
tained therein has been obtained from sources believed to be reliable. Although the Company             this corporate document, and, accordingly, investors should not place undue reliance on
believes these publications and reports to be reliable, it has not independently verified any of        any such forward-looking statements. Forward-looking information involves significant               Use of Non-IFRS Measures
the data or other statistical information contained therein, nor has it ascertained or validated        risks, assumptions, uncertainties and other factors that may cause actual future results or         This Presentation refers to Adjusted EBITDA because certain investors may use this infor-
the underlying economic or other assumptions relied upon by these sources. The Company                  anticipated events to differ materially from those expressed or implied in any forward-look-        mation to assess the Company’s performance and also determine the Company’s ability to
has no intention and undertakes no obligation to update or revise any such information or               ing statements and accordingly, should not be read as guarantees of future performance              generate cash flow. This data is furnished to provide additional information and are non-IF-
data, whether as a result of new information, future events or otherwise, except as, and to the         or results. Forward-looking information involves risks and uncertainties including, but not         RS measures and do not have any standardized meaning prescribed by IFRS. Accordingly,
extent required by applicable securities laws.                                                          limited to, the Company’s anticipated business strategies, anticipated trends in the Com-           these measures should not be considered in isolation nor as a substitute for analysis of the
                                                                                                        pany’s business and anticipated market share, that could cause actual results or events to          Company’s financial information reported under IFRS.
OUR VISION FROM THE OUTSET: To become the first and foremost streaming
enterprise in the cannabis industry. As our business platform began to take shape,
new opportunities forged new relationships, and those relationships are now the
foundation atop which our company is built. Today, our vision remains unchanged
while our ambition has indeed grown. We will continue to strengthen our platform,
provide value for our partners and bolster the industry through ingenuity and
innovation. Here, we believe tremendous results require grand ambition, honest
collaboration and relentless effort.

Auxly Cannabis Group Inc
www.auxly.com
KEY HIGHLIGHTS AND MILESTONES IN 2018:
Auxly continues to execute on its vertically integrated strategy.
Key Financial and Operational Highlights

Posititioned Auxly as a vertically integrated cannabis company with wholly-owned assets at each segment of
the value-chain
5 wholly owned subsidiaries and 13 streaming partners**
Auxly strategically organized into three segments of the industry value-chain: Upstream, Midstream and
Downstream
Significant working capital balance of $303M, inclusive of a $115M bought deal financing led by BMO Capital
Markets
Fully Funded capacity of 160,000kg per annum by 2021
Expanded Internationally with the acquisition of Inverell S.A.

** The Inverell acquisition remains subject to final regulatory approvals in Uruguay

Auxly Cannabis Group Inc
www.auxly.com
KEY HIGHLIGHTS AND MILESTONES IN 2018:
Auxly continues to execute on its vertically integrated strategy.

                                                                                                                                                          July/August 2018      August 2018
January 2018                   January 2018                         March 2018                    May 2018                       May 2018
Auxly raises $100M             Auxly finalizes investment           Auxly finalizes stream        Auxly acquires Robinson’s      Auxly announces $115     Kolab receives ACMPR Auxly enters
                                                                                                                                                          Sales License        strategic
through convertible            and partnership with Inner           with FSD Pharma to            Cannabis, a premium            million bought deal
                                                                                                                                                                               partnership with
debenture financing.           Spirit for retail distribution.      develop 620,000 sq ft         cannabis cultivator based      financing led by BMO     Dosecann receives    Delta 9 Cannabis
                                                                    former Kraft facility         in Nova Scotia                 Capital Markets          License Dealer

     January 2018                       February 2018                     April 2018                    May 2018                       June 2018                        August 2018
     Auxly expands                      Auxly announces                   Auxly acquires Dosecann,      Auxly announces exclusive      Auxly awarded recreational       Auxly acquires KGK
     internationally through            strategic JV with leading         Canada’s largest License      license for the Dixie Brands   retail store in Lloydminster,    Science, Canada’s
     Inverell acquisition in            greenhouse operator               Dealer facility in PEI as     portfolio in Canada and        Saskatchewan                     leading NHP Contract
     Uruguay.**                         Peter Quiring to develop          cornerstone Midstream         Mexico                                                          Research Organization
                                        and operate 1.4M sq. ft           asset
                                        operation in Leamington,
                                        ON

Auxly Cannabis Group Inc
www.auxly.com
FINANCIAL HIGHLIGHTS: Select summary of quarterly results

PERIOD ENDED (000s)                                  JUNE 30TH, 2018   DECEMBER 31ST, 2017
Cash and Cash Equivalents                               $295,803             $33,454
Total Current Assets                                    $310,326             $35,521
Investments in Streaming Partners and Subsidiaries      $178,912             $58,229
Total Assets                                            $478,866             $92,579
Long Term Convertible Debt                               $91,201             $17,738
Shareholder Equity                                      $357,828             $62,793

THREE MONTHS ENDED (000s)                            JUNE 30TH, 2018     JUNE 30TH, 2017
Income                                                    $282                  -
Total Expenses                                           $11,161             $1,599
Other Items                                              -$1,180              -$24
Total Comprehensive Profit or Loss                      -$14,216             -$1,583

SIX MONTHS ENDED (000s)                              JUNE 30TH, 2018     JUNE 30TH, 2017
Net cash used in operating activities                   -$16,560             -$2,980
Net cash used in investing activities                   -$23,135             -$2,450
Net cash from financing activities                      $302,044             -$51,519

Auxly Cannabis Group Inc
www.auxly.com
HOW WE VIEW OUR BUSINESS

  UPSTREAM                 MIDSTREAM                                   DOWNSTREAM
  Streaming Partners       Dosecann: Value Add and IP                  Distribution and Sales
  14 Partners              Extraction, Processing, Brands/Licensing,   Medical Market, Provincial Retail, Pharmacies,
                           R&D, Manufacturing                          Convenience Stores, International

  Domestic

  International

Auxly Cannabis Group Inc
www.auxly.com
MODEL FOR GROWTH: This is simple to articulate — as it should be. Auxly is
creating a world-class platform by forming partnerships with best-in-class
cultivators, product innovators and developers, researchers and marketers.
We provide our partners with ongoing cornerstone support in cultivation,
regulatory, construction, retail, branding and financing to help them realize
their full potential.
Wholly Owned Subsidiaries                                               Streaming Partners   Joint Ventures
Upstream                                                                Upstream             Upstream
Inverell*                                                               Beleave              Peter Quiring - GreenhouseCo
Kolab Project                                                           CannTx
Robinson’s Cannabis                                                     Sundial
                                                                        Green Relief
                                                                        Cannoe
Midstream
                                                                        FSD Pharma
Dosecann
                                                                        Lotus
KGK Science (acquired subsequent to quarter end)
                                                                        Groupe IDP
                                                                        Delta 9 Cannabis
Downstream                                                              Abcann
Kolab Retail Store in Lloydminster, SK                                  SGSC
Medical Sales through Kolab                                             Pontiac Group
                                                                        Curative Cannabis
*Auxly owns 80% of Inverell S.A., This transaction remains subject to   Level 10
final regulatory approvals in Uruguay

Auxly Cannabis Group Inc
www.auxly.com
DOWNSTREAM: Current Distribution Channels

Medical                                             Other Provincial Retailers

Kolab Project: Auxly has a wholly owned             Inner Spirit: Strategic alliance to supply up to
licensed facility in Carleton Place, Ontario.       50% of their annual inventory requirements
                                                    across their potential 95 franchise locations.
Auxly will be able to leverage our existing
licence to access the medical cannabis              Delta 9 Cannabis: strategic supply agreement.
regime and distribute cannabis products
directly to patients across Canada.                 National Access Cannabis (NAC): Strategic
                                                    supply agreements.

Pharmacies
                                                    Wholly Owned Retail Outlets
National chain of independent pharmacies:
Exclusive distribution alliance to develop and      Kolab Project: Obtained permit to operate
implement medical cannabis distribution             a cannabis retail store in Lloyminster,
and retail sale opportunities at all of the phar-   Saskatchewan.
macy group’s 40 locations across Canada.
                                                    International

                                                    Inverell (80% owned) provides a large-scale,
                                                    low-cost supply of CBD product in Uruguay
                                                    to supply international markets.

Auxly Cannabis Group Inc
www.auxly.com
2018 OBJECTIVES

Upstream                                                            Midstream                                                        Downstream

Continue to acquire cultivation capacity by developing facilities   Add value to the cannabis produced in the upstream business      Continue to focus on the development of high value medical
in Canada and internationally                                       segment through the application of intellectual property         and non-medical channels
Build a diverse cultivation platform comprised of wholly-owned      Continuously evaluate a broad range of applicable intellectual   We have made strategic decisions on which distribution
assets, stream partnerships, joint venture partnerships and         property including extraction and purification methodologies,    channels to prioritize based on its production ramp-up,
commercial offtake arrangements                                     trademark and know-how licensing, patent acquisition and         choosing to focus on higher margin medical channels and
                                                                    technology and product licensing                                 those non-medical channels that are owned by Auxly or where
Developing a robust supply pipeline is the cornerstone of the                                                                        Auxly holds an equity interest in the retailer
Auxly platform, providing the Company a secure and diverse          Develop our own cannabis-derived products and related
source of cannabis thereby allowing it to participate in the        intellectual property
entire cannabis value chain

Auxly Cannabis Group Inc
www.auxly.com
You can also read